Clinical trial
A Clinical Study to Evaluate Ambulatory Counterpulsation for the Treatment of Advanced Heart Failure: A Feasibility Study
NCT02645539 is registered in ClinicalTrials.gov with NuPulseCV as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Clinical Study to Evaluate Ambulatory Counterpulsation for the Treatment of Advanced Heart Failure: A Feasibility Study
- Lead sponsor
- NuPulseCV
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- April 30, 2016
- Completion date
- December 31, 2020
- Enrollment
- 100 (estimated)
- Sites
- 18
Conditions
As the registry lists them; a condition with its own page is linked.
heart failure nyha class iii, heart failure nyha class iv